Related Experiment Video
Updated: Mar 19, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
3.0K
Proteomic Findings in Melanoma.
Deepanwita Sengupta1, Alan J Tackett2
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, Arkansas 72205, USA.
Journal of Proteomics & Bioinformatics
|June 9, 2016
Summary
Proteomics, the study of proteins, aids in understanding melanoma, a dangerous skin cancer. Mass spectrometry is key for identifying diagnostic markers and treatment strategies for melanoma patients.
Area of Science:
- Proteomics
- Mass Spectrometry
- Cancer Biology
Background:
- Proteomics has rapidly advanced scientific understanding across disciplines.
- Mass spectrometry is crucial for analyzing complex biological samples.
- Clinical proteomics offers insights into drug action, resistance, and therapeutic assessment.
Purpose of the Study:
- To summarize the significant contributions of proteomics to melanoma research.
- To highlight proteomics' role in understanding this deadly skin cancer.
Main Methods:
- Utilizing mass spectrometry for proteomic analysis.
- Reviewing existing literature on proteomics in melanoma.
Main Results:
- Proteomics has identified potential predictive and diagnostic markers for melanoma.
- It aids in understanding melanoma's mechanisms and drug resistance.
- Proteomic data assists in evaluating melanoma treatment efficacy and toxicity.
Conclusions:
- Proteomics is a vital tool in advancing melanoma research.
- Its applications are crucial for developing improved diagnostic and therapeutic strategies for melanoma.
